MOVE: TGCT patient experience with vimseltinib
Part of Bones, joints & muscles, Cancer clinical trials.
This study is collecting real-world data from people with TGCT who have been prescribed vimseltinib. It is not testing the drug itself — it simply tracks your experience to help doctors understand how the treatment works outside of a clinical trial.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of Tenosynovial Giant Cell Tumor (TGCT) — a type of tumor that grows in the lining of joints or tendons.
- You have already been prescribed vimseltinib by your doctor, or the decision to start vimseltinib has been made.
- You agree to sign consent forms and allow the study team to access your medical records.
- You are not currently taking part in another clinical trial that tests vimseltinib.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called pimicotinib for people in Japan with tenosynovial giant cell tumor (TGCT) that cannot be removed by surgery. It aims to see if the drug can help with pain and stiffness caused by the tumor.
This study tests an experimental drug (DCC-3014) for people with TGCT, a non-cancerous joint tumor. The drug may help reduce pain and improve joint movement without the risks of surgery.
This trial tests whether taking a new drug (pimicotinib) before surgery can shrink the tumor and make surgery more effective, compared to having surgery right away. It is for people with a type of benign but aggressive joint tumor called diffuse TGCT.
This trial compares a newer cancer drug (velzatinib) with a standard treatment (imatinib) for gastrointestinal stromal tumors (GIST) that cannot be surgically removed or have spread. You would receive one of these two drugs to see which works better and is safer.
This trial tests an experimental treatment called VET3-TGI, which is injected directly into tumors. It is for people with advanced solid tumors who have already tried other treatments and are looking for new options.
This study tests a new pill called velzatinib for people with GIST that has spread or can't be removed by surgery, after other treatments have stopped working. It may help shrink the tumor or slow its growth.
Hear when a new Tenosynovial Giant Cell Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.